Clinical Trial Update: Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carrelizumab plus apatinib mesylate and radiotherapy for advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib Mesylate (apatinib)
• Carrelizumab (camrelizumab)

Snippet

Sponsor: Beijing Tsinghua Chang Gung Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN